ReGen Biologics, Inc. is an orthopedic products company that develops and manufactures tissue repair products for unmet markets in both the United States and globally. The Company's flagship product, the Collagen Meniscus Implant (CMI), is an implant designed to regenerate meniscus tissue in the human knee. CMI is cleared for sale in Europe, Australia and Chile, and is distributed outside the United States by the Centerpulse unit of Zimmer Holdings, Inc. The Company also sells the SharpShooter Tissue Repair System, a suturing device used to facilitate the surgical implantation of the CMI, as well as to perform other similar arthroscopic meniscal repair procedures. The SharpShooter is marketed through a worldwide distribution agreement with Linvatec Corporation, a subsidiary of ConMed. The SharpShooter is cleared for sale in the United States, Europe, Canada, Australia, Chile and Japan.